These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 23964790

  • 1. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.
    Hu Y, Guan X, Fan L, Li M, Liao Y, Nie Z, Jin L.
    J Headache Pain; 2013 Aug 21; 14(1):72. PubMed ID: 23964790
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial.
    Burmeister J, Holle D, Bock E, Ose C, Diener HC, Obermann M.
    Trials; 2015 Dec 03; 16():550. PubMed ID: 26634453
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Trigeminal Neuralgia: An Update on Systematic Review With Meta-analyses.
    Hu X, Xia Y, Li J, Wang X, Liu H, Hu J, Bi J, Wu J, Wang T, Lin Z, Xiong N.
    Clin J Pain; 2024 Jun 01; 40(6):383-392. PubMed ID: 38385501
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute treatment of trigeminal neuralgia with onabotulinum toxin A.
    Zúñiga C, Piedimonte F, Díaz S, Micheli F.
    Clin Neuropharmacol; 2013 Jun 01; 36(5):146-50. PubMed ID: 24045604
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Botulinum toxin A in the treatment of trigeminal neuralgia.
    Xia JH, He CH, Zhang HF, Lian YJ, Chen Y, Wu CJ, Ma YQ.
    Int J Neurosci; 2016 Jun 01; 126(4):348-53. PubMed ID: 26000810
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Topical Review: Potential Use of Botulinum Toxin in the Management of Painful Posttraumatic Trigeminal Neuropathy.
    Moreau N, Dieb W, Descroix V, Svensson P, Ernberg M, Boucher Y.
    J Oral Facial Pain Headache; 2016 Jun 01; 31(1):7-18. PubMed ID: 28118416
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neuromodulators for Atypical Facial Pain and Neuralgias: A Systematic Review and Meta-Analysis.
    Do TM, Unis GD, Kattar N, Ananth A, McCoul ED.
    Laryngoscope; 2021 Jun 01; 131(6):1235-1253. PubMed ID: 33037835
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety of botulinum toxin type A: a systematic review and meta-analysis.
    Naumann M, Jankovic J.
    Curr Med Res Opin; 2004 Jul 01; 20(7):981-90. PubMed ID: 15265242
    [Abstract] [Full Text] [Related]

  • 20. Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review.
    Naderi Y, Rad M, Sadatmoosavi A, Khaleghi E, Khorrami Z, Chamani G, Shabani M.
    Clin Exp Dent Res; 2024 Apr 01; 10(2):e882. PubMed ID: 38558383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.